mci 9038 has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Califf, RM; O'Shea, S; Reddan, D; Szczech, LA | 1 |
| Guzzi, LM; Hursting, MJ; McCollum, DA | 1 |
| Hursting, MJ; Swan, SK | 1 |
1 trial(s) available for mci 9038 and Kidney Diseases
| Article | Year |
|---|---|
The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Area Under Curve; Arginine; Female; Humans; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Middle Aged; Minnesota; Pipecolic Acids; Prospective Studies; Quebec; Sex Factors; Sulfonamides; Texas | 2000 |
2 other study(ies) available for mci 9038 and Kidney Diseases
| Article | Year |
|---|---|
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
Topics: Anticoagulants; Antithrombins; Arginine; Chronic Disease; Coronary Disease; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; United States | 2003 |
Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Heparin; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombocytopenia | 2006 |